Track topics on Twitter Track topics that are important to you
Australia Drug Delivery Devices Market Outlook to 2023 Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
GlobalData's new report, "Australia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Australia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume in units within market categories Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
The report also provides company shares and distribution shares data for each of these market categories, and global corporatelevel profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders KOLs, physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Market size and company share data for Drug Delivery Devices market categories Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
Annualized market revenues USD million and volume units data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market categories.
Global corporatelevel profiles of key companies operating within the Australia Drug Delivery Devices market.
Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
Develop business strategies by identifying the key market categories poised for strong growth in the future.
Develop marketentry and market expansion strategies.
Design competition strategies by identifying whostandswhere in the market.
Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.
Original Article: Australia Drug Delivery Devices Market Outlook to 2023 Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices [Report Updated: 01082017] Prices from USD $5995NEXT ARTICLE
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...